NEW YORK – Point-of-care diagnostic firm GBS announced on Thursday that it has entered a sponsored research agreement with Johns Hopkins Bloomberg School of Public Health to accelerate the development of saliva-based diagnostic tests.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.